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he presented work is destined to review the advances that had been made to study the role of 
thyroid hormone and thyroid hormone nuclear receptors in regulating the gene expression. 
Triiodothyronine (T3) and tetraiodothyronine (thyroxine or T4) are most important thyroid 
hormones. The thyroid hormones bind to their specific nuclear hormone receptors, as ligand, and play 
important role in gene expression and transcriptional gene regulation in human and higher animals. 
Thyroid hormone receptors form heterodimers by making combination with retinoid X receptors. The 
capability of heterodimerization of thyroid hormones generates novel complexes which allow altered 
specificity and higher affinity for DNA-receptor binding. Thyroid hormone receptors work as ligand 
activated transcription factor and play with transcriptional gene expression process. The consensus 
structural features of thyroid hormone receptors are N-terminal regulatory domain that contains 
activation function, the domain for strong gene expression and the domain for binding to DNA. The 
structures for individual domains have been extensively and reviewed through several latest and successful 
techniques.   
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Introduction  
Cells are capable to alter the expression of some of their 
genetic entities in accordance with their particular 
spatiotemporal context. In higher organisms, cells must 
respond to the external stimuli and signals for proper 
coordination, development, and the functioning of all 
organ systems, tissues, and whole organism (human and 
higher organisms) [1,2]. This ability is vital for their 
adaptation and survival in the fluctuating surroundings. 
Signal transduction through nuclear receptors is simpler 
because the cells are able to recognize the signal and 
show response directly by to interacting the nuclear 
genome [1]. 
Thyroid hormones are iodine containing peptides and 
are produced in the thyroid gland. Two very important 
thyroid hormones are triiodothyronine (T3) and 
tetraiodothyronine (thyroxine or T4). Thyroxine is 
reported to be the first hormone that was isolated and 
studied for structure determination, whereas, the T3 was 
identified in the circulation, many decades later [3]. On 
molar basis, T3 is 10-fold more active than T4 and plays 
dominant role in maintaining balance in thyroid levels. 
These hormones are vital for life and affect a broader 
range of mechanisms involved in development, 
differentiation, growth, morphogenesis, metabolism, 
and reproduction of humans and other higher 
organisms [4,5]. The thyroid stimulating hormone 
(TSH) and thyrotropin releasing hormone (TRH) which 
are produced by pituitary gland hypothalamus, control 
the balance between the production of thyroid 
hormones and their release. When the concentrations of 
thyroid hormones in blood are dropped below the 
certain levels, this decrease is detected by hypothalamus 
and the pituitary gland. Thyrotropin releasing hormone 
is produced out into the blood and acts upon pituitary 
gland to stimulate the release of thyroid stimulating 
hormone. In the response of boosted levels of thyroid 
stimulating hormone, the thyroid gland is stimulated to 
enhance the production of thyroid hormone. Hence, 
maintaining the normal blood level of thyroid hormone 
[6].  
At cellular level thyroid hormones perform their 
function as ligand and bind to the nuclear hormone 
receptors; which in turn behave as ligand-inducible 
transcription factors [4]. Thyroid hormone receptors 
bind to small ligand molecules, the thyroid hormone, 
and regulate transcription by binding to the sequences 
with high specificity for thyroid hormone [4,7,8]. These 
thyroid hormone-responsive sequences are observed in 
the promoter regions of target genes [7]. These 
molecules control important functions related to 
different diseases, for instance, diabetes, osteoporosis 
and cancer; and can be modified by drug design. Owing 
to this property nuclear hormone receptors are 
promising pharmacological targets [8].  
Methods 
Search Strategy and Selection Criteria  
In this study the domain structure of thyroid nuclear 
receptors and the functional mechanism of thyroid 
hormone receptors have been reviewed along with the 
discussion upon DNA hormone response elements to 
which they bind generally as homo- or heterodimers. 
The description has been limited around DNA binding-
dependent regulation by thyroid ligand. The mechanism 
of transcriptional repression has also been described 
with more detail. For the completion of this work the 
published research data has been studied from various 
sources. 
Discussion  
Thyroid Hormone Receptors 
How thyroid hormone plays role in gene expression. 
The answer can only be found when the working three-
dimensional structure of thyroid hormone receptors is 
known. The thyroid hormone receptors are grouped, in 
a large subfamily of the superfamily designated for the 
nuclear receptors. The receptors for small lipophilic 
hormones like retinoic acid, different orphan and 
peroxisome proliferator-activated receptors and vitamin 
D receptors are grouped in this subfamily among the 
thyroid receptors [4,7]. Thyroid hormone receptors in 
combination with retinoid X receptors form 
heterodimers [7].  
Due to heterodimerization novel complexes are 
produced by thyroid nuclear receptors that can bind 
DNA with altered specificity and higher affinity [1,9]. 
Whereas, in the monomeric form they show no 
considerable contributions in the transcriptional 
properties and only a little is known [10].  
Molecular cloning and structural and functional 
analyses revealed that all the members of the 
superfamily share common functional domain structure 
[11]. Nuclear hormone receptors work as ligand-
activated transcription factors and provide clear and 
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direct connection between the transcriptional responses 
and the signaling molecules that govern these processes 
[8].   
Overview of Structure 
The N-terminal regulatory domain also known as (A-B) 
contains AF-1 or Activation Function 1. It is important 
for transactivation of transcription and works without 
depending on the ligand [11,12]. The transcriptional 
activation of AF-1 is weak and functions in cooperation 
with AF-2 in the E-domain for strong gene expression. 
Various nuclear receptors possess variable sequence for 
A-B domain. The C domain or DNA-binding domain 
(DBD) is crucial for recognition of specific DNA 
sequences and for protein interactions. It is well 
conserved and its zinc fingers, called hormone response 
elements (HRE), are responsible for DNA binding 
specificity [11,13]. The Hinge region, (D) domain, is 
reported for connecting DNA-binding domain to the 
Ligand binding domain (LBD). It is recognized as 
flexible and for influencing intracellular trafficking 
[11,13]. LB domain or (E) shows strong conservation in 
structure and a bit less in sequence for various nuclear 
receptors. The LB domain bears AF-2 and its action 
depends upon the presence of bound ligand. In different 
nuclear receptors the sequence of F or C-terminal 
domain is highly variable [12]. The N-terminal, DNA-
binding, and ligand binding domains (A/B, C, and E 
respectively) possess independent folding and stable 
structures while a disordered and flexible 
conformational trend has been noted in hinge region 
and the C-terminal domains (D and F respectively) [14]. 
Figure 1: Structural Organization of Nuclear Receptors 
Top – Schematic 1D amino acid sequence of a nuclear receptor. 
Bottom – 3D structures of the DBD (bound to DNA) and LBD (bound 
to hormone) regions of the nuclear receptor. The structures shown are 
of the estrogen receptor. Experimental structures of N-terminal 
domain (A/B), hinge region (D), and C-terminal domain (F) have not 
been determined therefore are represented by red, purple, and orange 
dashed lines, respectively.” 
[Source:  Remec, Mark, "Biophysical and Structural Characterization 
of Nuclear Hormone Receptors" (2014). University of Tennessee 
Honors Thesis Projects. URL: 
http://trace.tennessee.edu/utk_chanhonoproj/1781] 
Crystallographic Studies 
It is depicted from the results of crystallographic studies 
carried upon thyroid receptors that ligand plays a 
structural role in the LB domain of thyroid receptor and 
influences the folding of its hydrophobic core. Further 
structural analysis directed to the genetic and 
biochemical studies. These studies have revealed that 
sites are essential to be present on the thyroid receptor 
ligand binding domain for the binding of co-activator 
proteins and for dimerization. When the patients 
possessing thyroid hormone resistance, syndrome of 
generalized resistance, were studied; it revealed that 
there was a mutation on thyroid receptor LB domain in 
a site very close to the thyroid hormone binding site 
[15]. 
Two subtypes of thyroid hormone receptor, TRα and 
TRβ, are involved in most of the physiological effects of 
thyroid hormones. Valadares et al., determined the 
affinity and selectivity of TRα and TRβ subtype for TR 
ligands using ligand and structure-guided approach 
which was pharmacophore-based [16]. Using CoMFA 
method, the comparative molecular field analysis, they 
obtained the three-dimensional quantitative structure-
selectivity and activity relationships (3D-QSSR) and 
(3D-QSAR) respectively, which were statistically 
reliable. With the help of 3D-QSSR models they 
determined halogen-bonds’ function in the selectivity of 
receptor for thyroid hormone [16,17]. 
Functional Mechanism of Thyroid Hormone 
Receptors 
Triiodothyronine (T3) binds to the nuclear receptors 
specified for thyroid hormone and regulates gene 
expression. Nuclear receptor co-activators are 
associated with ligand bound receptors and enhance 
gene transcription [18]. To promote transcription 
histones are acetylated with the help of enzymes 
recruited by co-activators and this course is sensitive to 
the metabolic state of cell [19,20]. Other wider level 
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studies have established the conclusion that direct 
interaction between DNA and nuclear receptors 
regulate the gene expression. However, these nuclear 
receptors may help opening chromatin in a way distinct 
from direct DNA binding [19]. For the stimulation of 
T3-regulated genes’ transcription, the TR complex 
employs co-activators (like some members of SRC 
family of proteins) [18]. Research studies regarding the 
T3 action reveal the importance of SRC1 for the 
increased TSH value in response to hypothyroidism. 
 
Figure 2: Crystallographic structure of the human progesterone 
receptor DNA-binding domain dimer (cyan and green) complexed 
with double strained DNA (magenta). Zinc atoms of are depicted as 
grey spheres. [Source: Roemer SC et al., [15]] 
 
Figure 3: Crystallographic structure of the ligand binding domain of 
the human RORγ (rainbow colored, N-terminus = blue, C-terminus = 
red) complexed with 25-hydroxycholesterol (space-filling model 
(carbon = white, oxygen = red) and the NCOA2 coactivator 
(magneta). [Source: Jin L et al., [17]] 
A heterodimer complex is formed between thyroid 
receptor and retinoid X receptor (RXR), this complex is 
capable to alter the gene expression by stimulating or 
repressing the gene transcription after binding onto a 
specific DNA sequences in the target genes. This DNA 
sequence is referred as thyroid response element (TRE) 
[6]. These hormone response elements are studied to be 
positioned in the regulatory sequences of target gene 
towards 5’ sides. In some situations these are present 
numerous kilobases upstream from the site of start of 
transcription, in the enhancer regions of target genes. 
Several studies revealed that a core recognition motif is 
made up of 6 bp sequence. Two consensus idealized 
recognition motif sequences have been identified and 
AGG/TTCA has been described for thyroid hormone 
receptors and for other non-steroidal receptors of 
nuclear receptors superfamily [4,21]; but a significant 
deviation from idealized consensus has been observed in 
the naturally occurring HREs. Most receptors (homo- or 
heterodimers) bind to the two core motifs elements 
(hexameric). In dimeric elements, the half-sites are 
described to be as direct repeats (DRs), palindromes 
(Pal), or inverted palindromes (IPs). The receptors may 
bind to these hormone response elements with 
receptor’s differential selectivity and specificity which is 
determined by spacing between the motifs and their 
arrangement [4]. Most of the studies have been focused 
on the transcriptional activation of target genes by 
thyroid ligand-nuclear receptor binding to positive 
elements but gene expression may also be repressed by 
nuclear receptors in the same manner. Thyroid 
hormones regulate gene expression by palindromic 
elements, AGGTCATGACCT along with retinoic acid 
[22]. Resultantly the thyroid and retinoic acid ligands 
can control gene expression through overlapping 
networks. Furthermore, the attachment of homodimers 
on to the DNA is repressed by thyroid hormone whereas 
it does not inhibits the binding of the heterodimers to 
latter; this way the creation of heterodimeric complexes 
is enhanced at the HREs [23].  
The co-repressor binds to the nuclear receptor in 
unliganded state and endorses gene repression. When 
unliganded, TR complex associates with co-repressors 
like nuclear receptor corepressor (NcoR) or silencing 
mediator for retinoid and thyroid hormone receptor 
(SMRT) and causes decreased transcription of T3-
regulated genes and antagonize the action of other 
nuclear receptor complexes [24,25]. It is achieved with 
the assistance of histone deacetylases (HDACs), 
recruited by Co-repressors, to the promoters of target 
genes for enhanced repression by unliganded TR [26].  
Sometimes thyroid ligand mediates negative 
regulation by binding to “negative TREs” in the genes of 
TSH and TRH.
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Thyroid negative regulation is also controlled by some 
other negative elements which bind to thyroid receptor 
homodimer when thyroid is absent, and to retinoid X 
receptor- thyroid receptor heterodimer (RXR/TR) when 
3, 3′,5-triiodothyronine (T3) is present. The negative 
elements, generally, are located very close to the 
transcription initiation sites and sometimes 
downstream to the TATA box [27-29]. These are also 
observed to be present at unusual site, at the 3′-
untranslated region [30]. These sequence show negative 
regulation only when these are present downstream of 
the transcription initiation site. To the date, the 
properties of the negative elements are not fully 
understood; but the location of these elements may a 
play an important role [4]. In addition to thyroid-
dependent gene activation, TR represses basal 
transcription when thyroid is absent. Binding of thyroid 
to the TR reliefs the transcriptional silencing and 
promotes gene activation. Presences of active silencing 
domains in TR were first demonstrated by Bahniahmad 
et al., [31]. 
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